From Ugi Multicomponent Reaction to Linkers for Bioconjugation
Iván Ramos‐Tomillero, Gema Pérez-Chacón, Beatriz Somovilla-Crespo, Francisco Sánchez‐Madrid, Carmen Cuevas, Juan M. Zapata, Juan Manuel Domı́nguez, Hortensia Rodrı́guez, Fernando Alberício
Abstract
Bioconjugation is a key approach for the development of novel molecular entities with clinical applications. The biocompatibility and specificity of biomolecules such as peptides, proteins, and antibodies make these macromolecules ideal carriers for selective targeted therapies. In this context, there is a need to develop new molecular units that cover the requirements of the next generation of targeted pharmaceuticals. Here, we present the design and development of a versatile and stable linker based on a N-alkylated α,α-dialkyl dipeptide for bioconjugation, with a particular focus on antibody-drug conjugates (ADCs). Starting with the well-known Ugi multicomponent reaction, the convenient chemical modification of the prepared adducts allowed us the obtention of versatile bifunctional linkers for bioconjugation. A conjugation strategy was tested to demonstrate the efficiency of the linker. In addition, a novel cytotoxic anti-HER2 ADC was prepared using the Ugi-linker approach.